AI-ACCELERATED DRUG DISCOVERY
Available from Reaxense
This protein is integrated into the Receptor.AI ecosystem as a prospective target with high therapeutic potential. We performed a comprehensive characterization of Mitochondrial proton/calcium exchanger protein including:
1. LLM-powered literature research
Our custom-tailored LLM extracted and formalized all relevant information about the protein from a large set of structured and unstructured data sources and stored it in the form of a Knowledge Graph. This comprehensive analysis allowed us to gain insight into Mitochondrial proton/calcium exchanger protein therapeutic significance, existing small molecule ligands, relevant off-targets, and protein-protein interactions.
Fig. 1. Preliminary target research workflow
2. AI-Driven Conformational Ensemble Generation
Starting from the initial protein structure, we employed advanced AI algorithms to predict alternative functional states of Mitochondrial proton/calcium exchanger protein, including large-scale conformational changes along "soft" collective coordinates. Through molecular simulations with AI-enhanced sampling and trajectory clustering, we explored the broad conformational space of the protein and identified its representative structures. Utilizing diffusion-based AI models and active learning AutoML, we generated a statistically robust ensemble of equilibrium protein conformations that capture the receptor's full dynamic behavior, providing a robust foundation for accurate structure-based drug design.
Fig. 2. AI-powered molecular dynamics simulations workflow
3. Binding pockets identification and characterization
We employed the AI-based pocket prediction module to discover orthosteric, allosteric, hidden, and cryptic binding pockets on the protein’s surface. Our technique integrates the LLM-driven literature search and structure-aware ensemble-based pocket detection algorithm that utilizes previously established protein dynamics. Tentative pockets are then subject to AI scoring and ranking with simultaneous detection of false positives. In the final step, the AI model assesses the druggability of each pocket enabling a comprehensive selection of the most promising pockets for further targeting.
Fig. 3. AI-based binding pocket detection workflow
4. AI-Powered Virtual Screening
Our ecosystem is equipped to perform AI-driven virtual screening on Mitochondrial proton/calcium exchanger protein. With access to a vast chemical space and cutting-edge AI docking algorithms, we can rapidly and reliably predict the most promising, novel, diverse, potent, and safe small molecule ligands of Mitochondrial proton/calcium exchanger protein. This approach allows us to achieve an excellent hit rate and to identify compounds ready for advanced lead discovery and optimization.
Fig. 4. The screening workflow of Receptor.AI
Receptor.AI, in partnership with Reaxense, developed a next-generation technology for on-demand focused library design to enable extensive target exploration.
The focused library for Mitochondrial proton/calcium exchanger protein includes a list of the most effective modulators, each annotated with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Furthermore, each compound is shown with its optimal docking poses, affinity scores, and activity scores, offering a detailed summary.
Mitochondrial proton/calcium exchanger protein
partner:
Reaxense
upacc:
O95202
UPID:
LETM1_HUMAN
Alternative names:
Electroneutral mitochondrial K(+)/H(+)exchanger; Leucine zipper-EF-hand-containing transmembrane protein 1
Alternative UPACC:
O95202; B4DED2; Q9UF65
Background:
The Mitochondrial proton/calcium exchanger protein, also known as Electroneutral mitochondrial K(+)/H(+) exchanger and Leucine zipper-EF-hand-containing transmembrane protein 1, is pivotal in maintaining mitochondrial morphology. It mediates calcium or potassium/proton antiport, crucial for mitochondrial tubular networks and respiratory chain supercomplexes assembly. Its role extends to proton-dependent calcium efflux and functioning as a mitochondrial proton/potassium exchanger, essential for tubular shape and cristae organization.
Therapeutic significance:
Linked to Neurodegeneration, childhood-onset, with multisystem involvement due to mitochondrial dysfunction, understanding the role of Mitochondrial proton/calcium exchanger protein could open doors to potential therapeutic strategies. Its involvement in mitochondrial maintenance and respiratory function highlights its potential as a target in treating mitochondrial disorders.
